Pfizer Turns To Insider Ian Read To See It Into Post-Lipitor Era
This article was originally published in The Pink Sheet Daily
Executive Summary
The 32-year Pfizer veteran will take over for Jeffrey Kindler in a succession viewed as a surprise by Wall Street.
You may also be interested in...
People In The News – Tracking The Latest Industry Personnel Moves
Pfizer elects current President and CEO Read chairman of the board; Former FDA Commissioner von Eschenbach joins BioTime board of directors; new leadership at Theraclone Sciences, DVS Sciences and Emerald BioStructures. More personnel announcements in this month’s column.
Former Pfizer CEO Kindler Named To Presidential Board On Government "Best Practices"
Jeffrey Kindler will bring the big pharma perspective to the newly-constituted President's Management Advisory Board.
Former Pfizer CEO Kindler Named To Presidential Board On Government "Best Practices"
Jeffrey Kindler will bring the big pharma perspective to the newly-constituted President's Management Advisory Board.